Pulmatrix, Inc. (NASDAQ:PULM) registered a -21.36% decrease, still its new closing price is 427.89% up from the company’s 1 year high of 3.89.It posted 154.81% gains in previous 5 sessions and is now the subject of 3 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 0 buy or better ratings. The 0 stock analysts following this company have an average price target at $15.00, with individual PT in the $15.00-$15.00 range. The shares moved at $2.65, implying that brokerage firms see shares losing about -6.95% in twelve months time.
Pulmatrix, Inc. (PULM) SEC Form 4 News
The stock is getting much attention these days as insiders are offloading shares while they posted a 349.15% rise year to date. A 10% Owner at Pulmatrix, Inc. (PULM) offloaded shares in a transaction closed on Wednesday June 17, 2015. Oculus Innovative Sciences, In sold 1,650,000 shares in the company at $2.75 each and collected $4,537,001 in proceeds. Oculus Innovative Sciences, In now owns 0 shares in the company after this transaction. A Director in the company, GILLIS STEVEN, disclosed a transaction on Tuesday June 16, 2015 that ended up paying $500,001 from the purchase of 29,100 shares at $17.2 per share.
Pulmatrix, Inc. (NASDAQ:PULM) Upcoming Results on Tap
Pulmatrix, Inc. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $0.50 in that period. Sales during the quarter are predicted to arrive at $80.86 million.
Pulmatrix, Inc. (PULM) Brokerage Update
Over the last six months and over the last three months, the shares of Pulmatrix, Inc. (PULM), have changed 25.00% and 85.31%, respectively.
